Literature DB >> 28964926

Managing Postoperative Pain After Minimally Invasive Gynecologic Surgery in the Era of the Opioid Epidemic.

Marron Wong1, Stephanie Morris2, Karen Wang3, Khara Simpson3.   

Abstract

In this review, we examine the evidence behind nonopioid medication alternatives, peripheral nerve blocks, surgical techniques, and postoperative recovery protocols that can help minimize and effectively treat postoperative pain after minimally invasive gynecologic surgery (MIGS). Because of the depth and heterogeneity of the data, a narrative review was performed of reported interventions. A comprehensive review was performed of PubMed, Embase, and the Cochrane Database with a focus on randomized controlled trials. In the absence of literature specific to benign gynecology, similar specialty or procedural data were reviewed. A variety of nonopioid medications, surgical techniques, and postoperative recovery protocols have shown significant improvements in postoperative pain after gynecologic surgery. Nonopioid medication options that are beneficial include acetaminophen, nonsteroidal anti-inflammatories, and antiepileptics. Incision infiltration with local anesthesia also significantly reduces pain. Surgically, minimally invasive approaches, reducing the laparoscopic trocar size to <10 mm, and evacuating the pneumoperitoneum at the end of the case all have significant benefits. Lastly, enhanced recovery pathways show promise in reducing pain after MIGS. By using a multimodal approach, minimally invasive gynecologic surgeons can help to minimize and manage postoperative pain with less reliance on opioid pain medications.
Copyright © 2017 American Association of Gynecologic Laparoscopists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28964926     DOI: 10.1016/j.jmig.2017.09.016

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  7 in total

1.  Improved Outcomes Associated With the Use of Intravenous Acetaminophen for Management of Acute Post-Surgical Pain in Cesarean Sections and Hysterectomies.

Authors:  Richard D Urman; Elaine A Boing; An T Pham; Victor Khangulov; Randi Fain; Brian H Nathanson; Xuan Zhang; George J Wan; Belinda Lovelace; Jessica Cirillo
Journal:  J Clin Med Res       Date:  2018-04-13

2.  Influences of UGT2B7 rs7439366 and rs12233719 Polymorphisms on Fentanyl Sensitivity in Chinese Gynecologic Patients.

Authors:  Zhenling Yang; Qingfeng Yin; Xiaodong Li
Journal:  Med Sci Monit       Date:  2020-05-13

3.  Factors that Lengthen Patient Hospitalizations Following Laparoscopic Hysterectomy.

Authors:  Laura Ramirez-Caban; Akshaya Kannan; Emily R Goggins; Marie E Shockley; Lisa B Haddad; E Britton Chahine
Journal:  JSLS       Date:  2020 Jul-Sep       Impact factor: 2.172

4.  Analgesic effects and distribution of cutaneous sensory blockade of quadratus lumborum block type 2 and posterior transversus abdominis plane block: an observational comparative study.

Authors:  Yuki Aoyama; Shinichi Sakura; Shoko Abe; Minori Wada; Yoji Saito
Journal:  Korean J Anesthesiol       Date:  2020-01-31

5.  Description and Comparison of Acute Pain Characteristics After Laparoscope-Assisted Vaginal Hysterectomy, Laparoscopic Myomectomy and Laparoscopic Adnexectomy.

Authors:  Sijia Chen; Wenwen Du; Xiuxiu Zhuang; Qinxue Dai; Jingwen Zhu; Haifeng Fu; Junlu Wang; Luping Huang
Journal:  J Pain Res       Date:  2021-10-19       Impact factor: 3.133

Review 6.  Systematic Review and Meta-Analysis of Perioperative Administration of Acetazolamide for Management of Postoperative Pain after Laparoscopy.

Authors:  Kaitlin McGrail; Andrew G Chapple; Gabrielle Stone; Elizabeth F Sutton; Neil R Chappell
Journal:  JSLS       Date:  2022 Jul-Sep       Impact factor: 1.789

7.  Laparoscopic Posterior Versus Lateral Transversus Abdominis Plane Block in Gynecology.

Authors:  Kelly Benabou; Soorin Kim; Christina H Tierney; Joel E Messom; Tassos C Kyriakides; Shabnam M Kashani; Dan-Arin Silasi; Masoud Azodi; Farinaz Seifi
Journal:  JSLS       Date:  2020 Jul-Sep       Impact factor: 2.172

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.